ICU Map
cardiovascular / hemodynamic

Refractory Shock Despite High-Dose Vasopressors

Advanced multimodal hemodynamic rescue: second-line vasopressors (vasopressin, angiotensin II), inotropic augmentation, stress-dose steroids, metabolic correction, and mechanical circulatory support evaluation.

Refractory shock is persistent tissue hypoperfusion (e.g., worsening lactate trend, oliguria, altered mental status, prolonged capillary refill) despite correction of reversible causes, appropriate initial resuscitation, and escalating/multiple vasoactive agents; no single norepinephrine dose defines the syndrome. It signals extreme pathological vasoplegia, concurrent myocardial dysfunction, critical endocrine failure, or uncorrected mechanical obstruction requiring multimodal hemodynamic rescue.

Caution

Dangerous Diagnosis Not to Miss: Dynamic Left Ventricular Outflow Tract (LVOT) Obstruction with systolic anterior motion (SAM) of the mitral valve (where inotropes worsen shock and beta-blockers/fluids improve it), concealed cardiac tamponade, massive occult retroperitoneal bleeding, and acute critical adrenal insufficiency.

1

RECOGNIZE & REASSESS

  • Escalating Vasoactive Requirement: Increasing norepinephrine and/or need for multiple agents despite adequate initial resuscitation should trigger immediate reassessment of shock phenotype; avoid defining refractory shock by one universal norepinephrine cutoff.

  • Persistent Hypoperfusion Markers: Arterial lactate failing to clear (> 2.0 mmol/L or rising), Mottling Score ≥ 3, base deficit worsening (> -6 mEq/L), mixed venous oxygen saturation (ScvO2) persistently < 65% or paradoxically elevated (> 85% indicating cellular dysoxia in terminal vasoplegia).

2

SCREEN FOR REVERSIBLE MECHANICAL / METABOLIC TRAPS

  • Check POCUS for Dynamic LVOT Obstruction: High-dose catecholamines in a hyperdynamic underfilled heart can cause systolic anterior motion (SAM) of the anterior mitral leaflet against the septum, obstructing forward aortic flow; inotropes worsen this condition drastically.

  • Check for Severe Acidemia (pH < 7.15): Severe hydrogen ion accumulation directly uncouples beta- and alpha-adrenergic receptors, rendering vascular smooth muscle unresponsive to catecholamines.

  • Check Ionized Calcium: Maintain ionized Ca2+ > 1.10–1.25 mmol/L (calcium is a mandatory cofactor for vascular smooth muscle contraction and myocardial excitation-contraction coupling).

3

MULTIMODAL VASOPRESSOR ESCALATION (NON-ADRENERGIC RESCUE)

  • Escalating septic shock: norepinephrine remains first-line. The 2026 SSC suggests adding vasopressin when norepinephrine doses are escalating; do not teach a mandatory fixed 0.03 U/min dose as the only acceptable regimen.

  • Corticosteroids: the 2026 SSC conditionally suggests IV corticosteroids for adults with septic shock. Hydrocortisone 200 mg/day is the most common regimen, but this should not be framed as treatment of a proven CIRCI diagnosis or tied to one universal vasopressor threshold.

  • Further vasoactive rescue is phenotype- and protocol-dependent. If MAP remains inadequate despite norepinephrine + vasopressin, SSC suggests adding epinephrine. Angiotensin II is an available vasoconstrictor for distributive shock; the current label starts at 20 ng/kg/min, allows titration up to 80 ng/kg/min during the first 3 h, and limits maintenance to <=40 ng/kg/min; thromboembolic risk and VTE prophylaxis must be considered.

  • Methylene blue: for refractory septic shock with escalating vasopressors, SSC 2026 found insufficient evidence to recommend for or against IV methylene blue. If used as rescue therapy, follow a specialist/local protocol and screen for G6PD deficiency plus serotonergic-drug/opioid interactions.

4

INOTROPIC & RIGHT VENTRICULAR RESCUE

5

ADVANCED MECHANICAL CIRCULATORY SUPPORT (MCS)

Caution

Common Diagnostic Trap: Escalating a single adrenergic vasopressor (Norepinephrine) to massive doses (> 1.0–1.5 mcg/kg/min) without initiating multi-receptor blockade (Vasopressin + Hydrocortisone). Single-agent excessive adrenergic exposure induces severe peripheral digital necrosis, splanchnic vasoconstriction, and tachyarrhythmias.

Destination Topics

  • Shock: Advanced perfusion indices, microcirculatory dysfunction, and oxygen consumption.

  • Septic Shock: Vasopressor pathways, Corticus/ADRENAL steroid trials, and refractory resuscitation.

  • Cardiogenic Shock: SCAI Stage D/E refractory shock algorithms and ECMO/Impella.

  • Vasopressors & Inotropes: Receptor profiles, receptor downregulation, and non-adrenergic rescue.

  • RV Failure: 4-pillar resuscitation and pulmonary vasodilator delivery.

Evidence status

Review metadata not yet recorded.

Status, review dates and guideline versions appear here once editorial metadata is authored for this content.

Deep-Dive Topic Destinations (12)

Reference Knowledge
Shock: Foundational Critical Care Frameworkcardiovascular

Cellular dysoxia, DO2/VO2 physiology, the 4 shock phenotypes, dynamic fluid responsiveness (PLR/PPV) vs fluid tolerance (VExUS), and vasoactive pharmacology.

Explore Topic →
Septic Shockcardiovascular

The subset of sepsis with profound circulatory and cellular/metabolic abnormality — clinically identified by a vasopressor requirement to maintain MAP ≥ 65 mmHg plus lactate > 2 mmol/L despite adequate fluid resuscitation.

Explore Topic →
Cardiogenic Shockcardiovascular

Primary pump failure, SCAI staging (A–E), PAC hemodynamics (CPO, PAPi), inotrope selection, emergent revascularization, and mechanical circulatory support.

Explore Topic →
Obstructive Shockcardiovascular

Extracardiac mechanical barriers to filling or ejection: Massive PE, Cardiac Tamponade, Tension Pneumothorax, and Auto-PEEP.

Explore Topic →
Acute Right Ventricular Failurecardiovascular

RV anatomy and ischemia spiral, ventricular interdependence (D-sign), echocardiographic metrics (TAPSE, S', PAPi, VExUS), and the 4-pillar resuscitation strategy.

Explore Topic →
Pulmonary Hypertension & Acute Decompensationcardiovascular

Hemodynamic classification, right ventricular afterload reduction, selective pulmonary vasodilation, and pulmonary hypertensive crisis management.

Explore Topic →
Acute Mesenteric Ischemia (AMI)gi-hepatic

Rapid biphasic CTA diagnosis, mechanism-specific revascularization (embolism vs thrombosis vs venous thrombosis vs NOMI), individualized therapeutic anticoagulation, and selective second-look laparotomy.

Explore Topic →
Severe Acute Pancreatitisgi-hepatic

Revised Atlanta severity staging, goal-directed fluid resuscitation informed by WATERFALL, oral/enteral nutrition as tolerated, antibiotic avoidance in sterile necrosis, and the PANTER step-up approach.

Explore Topic →
Burns & Major Burn Critical Carespecial-critical-care

Inhalation injury management, endpoint-driven fluid resuscitation, avoidance of fluid creep, bedside escharotomy, and hypermetabolic catabolism support.

Explore Topic →
ECMO: Physiology, Bedside Management & Troubleshootingspecial-critical-care

Specialist-level VV/VA ECMO bedside management: selection, cannulation, gas exchange, hemodynamics, anticoagulation, circuit troubleshooting, organ support, ultrasound, ECPR, weaning and decannulation.

Explore Topic →
Cardiac Arrest & Post–Cardiac Arrest Carecardiovascular

Multimodal resuscitation, post-cardiac arrest syndrome management, targeted temperature control, and delayed neuroprognostication.

Explore Topic →
Acid-Base Disorders: Comprehensive Critical Care Approachrenal

Stepwise 6-step interpretation algorithm, compensation formulas, albumin-corrected anion gap, delta ratio, and Stewart physicochemical (SID) principles.

Explore Topic →